Medicare Enrolled
Dr. Kevin Musto, M.D.
Internal Medicine · Pittston, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Musto from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Musto?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Musto
Dr. Kevin Musto is an internal medicine specialist in Pittston, PA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Musto performed 8,027 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Musto received a total of $4,983 from 40 pharmaceutical and/or device companies across 336 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Musto is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 1% volume in PA
$4,983 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,027
Medicare services
Top 1% in PA for internal medicine
Not available
Unique patients (not deduplicated)
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,040 | $18 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
945 | $83 | $200 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
680 | $124 | $285 |
| Annual depression screening | 560 | $18 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
529 | $58 | $125 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
482 | $82 | $251 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
293 | $54 | $125 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
275 | $59 | $175 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
272 | $9 | $40 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
238 | $37 | $129 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
238 | $1 | $10 |
| Annual alcohol misuse screening, 5 to 15 minutes | 228 | $18 | $45 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
175 | $101 | $356 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
170 | $28 | $100 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
141 | $37 | $129 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
103 | $72 | $140 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
103 | $29 | $40 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
95 | $37 | $135 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
67 | $155 | $450 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
59 | $14 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
44 | $94 | $325 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
43 | $88 | $250 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
43 | $30 | $106 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $123 | $275 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
33 | $79 | $299 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $125 | $425 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
25 | $29 | $40 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
20 | $283 | $464 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
17 | $58 | $187 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $69 | $200 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
14 | $209 | $600 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
13 | $161 | $325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,983
Total received (2018-2024)
Avg $712/year across 7 years
Top 12% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
336
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,911
2023
$1,546
2022
$395
2021
$117
2020
$326
2019
$428
2018
$260
Payments by company (2024)
PFIZER INC.
$285
ABBVIE INC.
$235
AstraZeneca Pharmaceuticals LP
$216
Amgen Inc.
$191
Novo Nordisk Inc
$190
GlaxoSmithKline, LLC.
$186
Lilly USA, LLC
$162
Exact Sciences Corporation
$83
Astellas Pharma US Inc
$77
Abbott Laboratories
$69
Otsuka America Pharmaceutical, Inc.
$61
E.R. Squibb & Sons, L.L.C.
$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
Xeris Pharmaceuticals, Inc.
$19
Lundbeck LLC
$17
Phathom Pharmaceuticals, Inc.
$16
Paratek Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 38.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$725
ABBVIE INC.
$721
Novo Nordisk Inc
$522
PFIZER INC.
$518
Lilly USA, LLC
$416
GlaxoSmithKline, LLC.
$409
AstraZeneca Pharmaceuticals LP
$321
E.R. Squibb & Sons, L.L.C.
$154
Exact Sciences Corporation
$125
Astellas Pharma US Inc
$117
Abbott Laboratories
$116
Novartis Pharmaceuticals Corporation
$87
Otsuka America Pharmaceutical, Inc.
$82
Bayer Healthcare Pharmaceuticals Inc.
$76
Amarin Pharma Inc.
$51
AbbVie Inc.
$49
Janssen Pharmaceuticals, Inc
$44
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$43
Takeda Pharmaceuticals U.S.A., Inc.
$34
Shield Therapeutics Inc
$32
Collegium Pharmaceutical, Inc.
$31
Avanir Pharmaceuticals, Inc.
$29
SANOFI-AVENTIS U.S. LLC
$26
Boston Scientific Corporation
$24
Merck Sharp & Dohme Corporation
$22
Daiichi Sankyo Inc.
$20
Xeris Pharmaceuticals, Inc.
$19
Biohaven Pharmaceuticals, Inc.
$18
Lundbeck LLC
$17
Phathom Pharmaceuticals, Inc.
$16
Allergan Inc.
$16
Paratek Pharmaceuticals, Inc.
$15
Mannkind Corporation
$14
Merck Sharp & Dohme LLC
$14
Supernus Pharmaceuticals, Inc.
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
Philips Electronics North America Corporation
$12
Allergan, Inc.
$11
Boehringer Ingelheim Pharmaceuticals, Inc.
$11
Sumitomo Pharma America, Inc.
$1
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · AIRSUPRA · AREXVY · Aimovig · Amitiza · BREZTRI · Belbuca · CAMZYOS · CHANTIX · COMIRNATY · Cologuard Collection Kit · Dexilant · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GEMTESA · GENERAL - PAIN MANAGEMENT · GVOKE HYPOPEN · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LINZESS · MOUNJARO · MYRBETRIQ · NUEDEXTA · NURTEC ODT · NUZYRA · Otezla · Ozempic · PAXLOVID · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · REXULTI · Repatha · Rybelsus · SOLIQUA 100/33 · SPECTRA WAVEWRITER · SYNTHROID · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · Trilogy 100 · UBRELVY · Uloric · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
272
County median income
$62,321
Nearest hospital to ZIP centroid (approximate)
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
5.2 mi
5.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Musto is a clinical cardiology specialist, with above-average Medicare volume (top 1% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Musto experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Musto performed 2,040 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Musto receive payments from pharmaceutical companies?
Yes. Dr. Musto received a total of $4,983 from 40 companies across 336 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Musto's costs compare to other internal medicine physicians in Pittston?
Dr. Musto's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Musto) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Pittston
Browse internal medicine physicians in Pittston ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology